Tuesday, February 28, 2006 11:55:19 PM
Tuesday February 28, 6:52 pm ET
BIRMINGHAM, Ala., Feb. 28 /PRNewswire-FirstCall/ -- HealthSouth Corporation (OTC Pink Sheets: HLSH - News) priced $400 million of convertible perpetual preferred stock through a private placement to qualified institutional buyers.
Shares of the preferred stock will be convertible into the Company's common stock at an initial conversion price of $6.10 per share. Holders of preferred stock will generally be entitled to receive dividends at the rate of 6.5% per year, payable quarterly. The Company expects this transaction to close on or about March 7, 2006.
The purpose of the preferred stock issuance is to reduce HealthSouth's outstanding indebtedness. If HealthSouth successfully completes its previously announced recapitalization transactions, the amount of senior unsecured interim term loans HealthSouth will be permitted to borrow in connection with the recapitalization transactions will be reduced by the amount of gross proceeds that HealthSouth receives from the preferred stock issuance. If the recapitalization transactions are not completed, HealthSouth will use the net proceeds that it receives from the preferred stock issuance to repay a portion of its outstanding senior unsecured indebtedness.
The convertible perpetual preferred stock and the underlying common stock issuable upon conversion have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This news release does not constitute an offer to sell, or solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering would be unlawful.
Recent EHC News
- Encompass Health declares dividend on common stock • PR Newswire (US) • 05/02/2024 01:47:00 PM
- Encompass Health opens request for grant applications • PR Newswire (US) • 05/01/2024 08:29:00 PM
- Encompass Health reports results for first quarter 2024 • PR Newswire (US) • 04/24/2024 08:15:00 PM
- Encompass Health announces date of 2024 first quarter earnings call • PR Newswire (US) • 04/10/2024 08:30:00 PM
- Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in San Antonio • PR Newswire (US) • 04/03/2024 08:30:00 PM
- Encompass Health announces annual stockholder meeting date • PR Newswire (US) • 04/02/2024 08:30:00 PM
- Encompass Health announces Andrew Baird as senior vice president of public policy, legislation and regulations • PR Newswire (US) • 03/27/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:38:49 PM
- Encompass Health and Piedmont announce plans to build a 40-bed inpatient rehabilitation hospital in Loganville, Georgia • PR Newswire (US) • 03/07/2024 12:54:00 PM
- Encompass Health to present at Barclays Global Healthcare Conference • PR Newswire (US) • 03/05/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:28:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 07:38:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 07:36:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 07:34:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 08:29:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 08:27:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 08:25:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 08:24:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 08:22:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 08:19:56 PM
- Encompass Health declares dividend on common stock • PR Newswire (US) • 02/28/2024 02:19:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 10:09:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:28:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:26:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:24:58 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM